Gonadotropin in cognition and Alzheimer's disease: Therapeutic Implications

促性腺激素在认知和阿尔茨海默氏病中的作用:治疗意义

基本信息

  • 批准号:
    8103837
  • 负责人:
  • 金额:
    $ 25.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-15 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Estrogen is thought to play an important role in age-related cognitive decline, neuronal plasticity, as well as the pathogenesis of Alzheimer disease (AD). Epidemiological evidence linked decreased incidence of AD and cognitive decline in women previously exposed to hormone (estrogen) replacement therapy (HRT). Further, clinical data correlates estrogen deficiency to the etiology of AD, yet initiating HRT in elderly (age 65 and over) post-menopausal women failed to improve cognitive performance. These findings have led many in the field, including us, to re-examine the role of estrogen in cognition and AD and to look beyond the direct effects of estrogen to more indirect, though perhaps no less important, effects. To this end, declining levels of sex steroids in women and men, albeit to a lesser degree, result in increases in gonadotropins such as luteinizing hormone (LH) through loss of feedback inhibition. LH, like estrogen, is modulated by HRT and serum levels of LH are higher in AD patients compared to aged-matched controls. Moreover, recent published and preliminary data, including our own studies, show that LH is capable of modulating cognitive behavior and associated neuronal plasticity markers, is present in the brain, has the highest levels of receptors in the hippocampus, is increased in the AD brain, and is capable of altering amyloid-b protein precursor processing. In this proposal, our goal is to dissect the hormonal contributions and interactions of estrogen and LH on cognition, synaptic plasticity, and AD pathogenesis using animal models of menopause and AD. Specifically, we propose to measure cognitive behavior [Morris Water Maze (MWM) task], neuronal plasticity as measured by structural and functional changes in synaptic remodeling, and cognitive decline (MWM) and amyloid-b synthesis and deposition in female C57/BLJ6 and AD transgenic mice (Tg2576) after ovariectomy and thereafter assess the effect of a "critical window" of efficacy of pharmacological manipulation of estrogen and LH levels, either singly or in combination. This systematic analysis will not only address the importance of hormonal action in cognition but will also begin to dissect the individual contributions of estrogen and LH and how these aspects are affected by the post-menopausal timing of HRT. PUBLIC HEALTH RELEVANCE: Postmenopausal changes in HPG-axis hormones, in particular estrogen, is tightly linked to cognitive impairment in older individuals and development of AD. This proposal trascends beyond the study of estrogen to determine the influence of other HPG-axis hormones. Specifically, the objective of this body of work is to investigate whether luteinizing hormone is a central mediator of such impairment, independently or in conjunction with estrogen. Outcomes of the proposal are not only important from a scientific perspective but could lead to immediate novel therapeutic regimens.
描述(由申请人提供):雌激素被认为在与年龄相关的认知下降,神经元可塑性以及阿尔茨海默氏病(AD)的发病机理中起着重要作用。流行病学证据将AD的发病率降低和先前暴露于激素(雌激素)替代疗法(HRT)的女性的认知下降联系在一起。此外,临床数据将雌激素缺乏症与AD的病因相关,但在绝经后妇女的老年人(65岁及以上)启动HRT未能提高认知表现。这些发现导致了包括我们在内的领域中的许多人重新检查雌激素在认知和AD中的作用,并超越了雌激素对更间接的直接影响,尽管也许同样重要,但也是如此。为此,尽管程度较低,但男性和男性的性类固醇水平下降,导致促性腺激素的增加,例如通过失去反馈抑制,例如黄体生成激素(LH)。与雌激素一样,LH受到HRT的调节,与年龄匹配的对照相比,AD患者的血清水平更高。此外,最近发布和初步数据(包括我们自己的研究)表明,LH能够调节认知行为和相关的神经元可塑性标记物,存在于大脑中,在AD大脑中具有最高水平的受体受体,并且能够改变淀粉样蛋白-B蛋白质前体处理。在此提案中,我们的目标是使用更年期和AD的动物模型剖析雌激素和LH对认知,突触可塑性和AD发病机理的激素贡献和相互作用。具体而言,我们建议测量认知行为[Morris Water Maze(MWM)任务],通过突触重塑的结构和功能变化来衡量的神经元可塑性,以及认知能力下降(MWM)以及淀粉样蛋白-B的合成和女性C57/BLJ6和Ad Transententententent of Transgenic Mite(Tg2576)的效果(TG2576)的效果(雌激素和LH水平的药理学操纵的功效,无论是单独的还是组合。这种系统的分析不仅将解决荷尔蒙作用在认知中的重要性,而且还将开始剖析雌激素和LH的个体贡献,以及这些方面如何受到HRT的绝经后时间的影响。公共卫生相关性:HPG-轴激素的绝经后变化,尤其是雌激素,与老年人的认知障碍与AD的发展密切相关。该提议超出了雌激素的研究,以确定其他HPG轴激素的影响。具体而言,这项工作的目的是研究黄体生成激素是独立或与雌激素结合的这种损害的中心介体。该提案的结果不仅从科学角度来看很重要,而且可能导致直接的新型治疗方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gemma Casadesus其他文献

Gemma Casadesus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gemma Casadesus', 18)}}的其他基金

Characterization of transcriptome changes in diet-induced progression to METS/T2D to identify earliest and sex-specific neurodegenerative foci for AD development
饮食诱导的 METS/T2D 进展中转录组变化的表征,以确定 AD 发展的最早和性别特异性神经退行性病灶
  • 批准号:
    9809399
  • 财政年份:
    2019
  • 资助金额:
    $ 25.99万
  • 项目类别:
Characterization of transcriptome changes in diet-induced progression to METS/T2D to identify earliest and sex-specific neurodegenerative foci for AD development
饮食诱导的 METS/T2D 进展中转录组变化的表征,以确定 AD 发展的最早和性别特异性神经退行性病灶
  • 批准号:
    10359377
  • 财政年份:
    2019
  • 资助金额:
    $ 25.99万
  • 项目类别:
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic
促性腺激素参与认知和阿尔茨海默病:治疗意义
  • 批准号:
    7897674
  • 财政年份:
    2008
  • 资助金额:
    $ 25.99万
  • 项目类别:
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implications
促性腺激素参与认知和阿尔茨海默病:治疗意义
  • 批准号:
    8850239
  • 财政年份:
    2008
  • 资助金额:
    $ 25.99万
  • 项目类别:
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic
促性腺激素参与认知和阿尔茨海默病:治疗意义
  • 批准号:
    7507090
  • 财政年份:
    2008
  • 资助金额:
    $ 25.99万
  • 项目类别:
Gonadotropin involvement in cognition and Alzheimer's disease: Therapeutic Implic
促性腺激素参与认知和阿尔茨海默病:治疗意义
  • 批准号:
    7673705
  • 财政年份:
    2008
  • 资助金额:
    $ 25.99万
  • 项目类别:

相似国自然基金

微囊泡介导肺泡上皮祖细胞醋酸盐代谢重编程向AT2细胞分化促进ARDS炎症修复的作用机制
  • 批准号:
    82360020
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
  • 批准号:
    82273313
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
络合萃取法提取生物油酚类化合物的效能及机理研究
  • 批准号:
    21206142
  • 批准年份:
    2012
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
  • 批准号:
    10836298
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
Spatial Acetyl-CoA metabolism as a regulator of Hallmarks of Aging
空间乙酰辅酶A代谢作为衰老标志的调节剂
  • 批准号:
    10901039
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
Epigenetic-metabolic aspects of alcohol use disorder and early developmental alcohol exposure
酒精使用障碍和早期发育酒精暴露的表观遗传代谢方面
  • 批准号:
    10745787
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
Novel Pharmacological Treatment for Preeclampsia
先兆子痫的新型药物治疗
  • 批准号:
    10758980
  • 财政年份:
    2023
  • 资助金额:
    $ 25.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了